Bacillus Anthracis Infections Market Industry shared in News Research Report
Transparency Market Research presents this most up-to-date research on "Bacillus Anthracis Infections Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 2024" Global Bacillus Anthracis Infections Market: Overview Bacillus anthracis is a type of bacteria that causes an acute disease called anthrax. Bacillus anthracis can infect both animals and humans. Bacillus anthracis is able to form a bacterial spore and is able to survive for prolonged period of time, even for centuries, in any harsh and mild conditions. When the spores of Bacillus anthracis are inhaled, swallowed or adhered to a lesion, they get reactivated and start rapid multiplication in the body of host. An important feature of Bacillus anthracis is it doesn’t spread from one person to another by direct contact. It gets spread by clothes, shoes and utensils used by infected person. The bacterium was discovered in 1876 by Robert Koch. The major symptoms of the disease are identified from cutaneous sites, gastrointestinal and pulmonary infections. Pulmonary infections such as, cold, flu, pneumonia and respiratory failure are considered as important indications for Bacillus anthracis infections. Whereas, major gastrointestinal symptoms include chronic GI pain, severe diarrhea and vomiting of blood. The anthrax caused to skin is also called as Hide Porter’s disease. This is very chronic and life-threatening disease in which the skin develops black center spotted boiled skin lesions. Although life-threatening, it does not cause any pain or sensation to patient, but gradually converts into necrotic ulcer. Diagnosis of Bacillus anthracis infection is done by gram test in laboratory, Ascoli test, PCR assays, chest CT scan and immunofluroscence microscopical diagnostic tests. Global Bacillus Anthracis Infections Market: Major Segments The market of Bacillus anthracis infection is segmented on the basis of treatments, such as, preventive treatment and disease treatment. Prevention treatment is divided into vaccines such as, Pasteur’s vaccine, Sterne’s vaccine, British anthrax vaccines, Russian Anthrax vaccines, and American anthrax vaccines (BioThrax) and prophylaxis care. Further, infection treatment include antibiotics (penicillin, ciprofloxacin, erythromycin, doxycycline and others), monoclonal antibodies, such as, Raxibacumab and others. Additionally, the market is segmented on the basis of geography, such as, North America, Europe, Asia-Pacific and Rest of the World (RoW). At present, North America and Europe are the most prominent markets, owing to growing prevalence of Bacillus anthracis infection and anthrax disease. However, Asia-Pacific and some countries in RoW